Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Anti-Müllerian hormone (AMH) is produced by the granulosa cells of preantral and small antral follicles and its levels can be assessed in serum. Since the number of ovarian follicles declines with increasing age, AMH levels might be used as a marker for ovarian ageing. Therefore, we studied the relationship between AMH levels and ovarian response during ovarian stimulation for IVF. METHODS: A total of 130 patients undergoing their first IVF treatment cycle using a long protocol with GnRH agonist was prospectively included. Blood withdrawal was performed and the number of antral follicles was assessed by ultrasound on day 3 of a spontaneous cycle. Poor response and the number of oocytes were used as primary outcome measures. In a random subset of 23 patients a GnRH agonist stimulation test was performed to investigate whether a rise in FSH and LH would affect AMH levels. RESULTS: The data of 119 patients were analysed. Serum AMH levels were highly correlated with the number of antral follicles (r = 0.77; P < 0.01) and the number of oocytes retrieved (r = 0.57, P < 0.01). A negative association was found between AMH levels and poor ovarian response (fewer than 4 oocytes or cycle cancellation; OR 0.82, 95% CI 0.75-0.90, P < 0.01). Inclusion of inhibin B and FSH concentrations to AMH in a multivariate model improved the prediction of ovarian response. The post GnRH agonist rise in FSH and LH levels did not influence AMH values. CONCLUSIONS: Poor response in IVF, indicative of a diminished ovarian reserve, is associated with reduced baseline serum AMH concentrations. In line with recent observations it appears that AMH can be used as a marker for ovarian ageing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of ovarian follicular development in primates: facts and hypotheses
GOUGEON, A. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-2-121 · Cited by 1,497
The variability of female reproductive ageing
te Velde, E. R. (2002) · Human Reproduction Update · doi:10.1093/humupd/8.2.141 · Cited by 1,214
Control of Primordial Follicle Recruitment by Anti-Müllerian Hormone in the Mouse Ovary1
Durlinger, A. L. L., Kramer, P., Karels, B., de Jong, F. H., Uilenbroek, J. T. J., Grootegoed, J. A., & Themmen, A. P. N. (1999) · Endocrinology · doi:10.1210/endo.140.12.7204 · Cited by 1,011
Measurement of dimeric inhibin B throughout the human menstrual cycle
Groome, N. P. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.4.1401 · Cited by 946
Antimüllerian hormone serum levels: a putative marker for ovarian aging
de Vet, A., Laven, J. S. E., de Jong, F. H., Themmen, A. P. N., & Fauser, B. C. J. M. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02993-4 · Cited by 887
Anti-Mullerian Hormone Attenuates the Effects of FSH on Follicle Development in the Mouse Ovary
Durlinger, A. L. L., Gruijters, M. J. G., Kramer, P., Karels, B., Kumar, T. R., Matzuk, M. M., Rose, U. M., de Jong, F. H., Uilenbroek, J. T. J., Grootegoed, J. A., et al. (2001) · Endocrinology · doi:10.1210/en.142.11.4891 · Cited by 772
Müllerian-inhibiting substance function during mammalian sexual development
Behringer, R. R., Finegold, M. J., & Cate, R. L. (1994) · Cell · doi:10.1016/0092-8674(94)90251-8 · Cited by 679
Wilms’ tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression.
Nachtigal, M. W., Hirokawa, Y., Enyeart-VanHouten, D. L., Flanagan, J. N., Hammer, G. D., & Ingraham, H. A. (1998) · Cell · doi:10.1016/s0092-8674(00)81172-1 · Cited by 591
Manipulation of Human Ovarian Function: Physiological Concepts and Clinical Consequences*
Fauser, B. C. J. M., & van Heusden, A. M. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0290 · Cited by 509
Seifer, D. B., MacLaughlin, D. T., Christian, B. P., Feng, B., & Shelden, R. M. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)03201-0 · Cited by 494
Baarends, W. M., Uilenbroek, J. T., Kramer, P., Hoogerbrugge, J. W., van Leeuwen, E. C., Themmen, A. P., & Grootegoed, J. A. (1995) · Endocrinology · doi:10.1210/endo.136.11.7588229 · Cited by 461
Targeted Mutagenesis of the Endogenous Mouse Mis Gene Promoter
Arango, N. A., Lovell-Badge, R., & Behringer, R. R. (1999) · Cell · doi:10.1016/s0092-8674(00)81527-5 · Cited by 449
Bancsi, L. F. J. M. M., Broekmans, F. J. M., Eijkemans, M. J. C., de Jong, F. H., Habbema, J. D. F., & te Velde, E. R. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02983-1 · Cited by 441
Mullerian inhibiting substance in humans: normal levels from infancy to adulthood
Lee, M. M. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.2.571 · Cited by 431
Morphology and Morphogenesis of the Stein-Leventhal Ovary and of So-called “Hyperthecosis”
HUGHESDON, P. E. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198202000-00001 · Cited by 429
Rajpert-De Meyts, E., Jørgensen, N., Græm, N., Müller, J., Cate, R. L., & Skakkebæk, N. E. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6047 · Cited by 373
Mullerian Inhibiting Substance: A Gonadal Hormone with Multiple Functions*
LEE, M. M., & DONAHOE, P. K. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-2-152 · Cited by 345
Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome
Seifer, D. B., Lambert-Messerlian, G., Hogan, J. W., Gárdiner, A. C., Blazar, A. S., & Berk, C. A. (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)81865-1 · Cited by 325
Production of Anti-Müllerian Hormone: Another Homology between Sertoli and Granulosa Cells
VIGIER, B., PICARD, J.-Y., TRAN, D., LEGEAI, L., & JOSSO, N. (1984) · Endocrinology · doi:10.1210/endo-114-4-1315 · Cited by 279
Cook, C. L., Siow, Y., Brenner, A. G., & Fallat, M. E. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02944-2 · Cited by 266
Serum müllerian-inhibiting substance levels during normal menstrual cycles
Cook, C. L., Siow, Y., Taylor, S., & Fallat, M. E. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00639-1 · Cited by 237
Land, J. A., Yarmolinskaya, M. I., Dumoulin, J. C. M., & Evers, J. L. H. (1996) · Fertility and Sterility · doi:10.1016/s0015-0282(16)58269-7 · Cited by 226
Hall, J. E., Weltand, C. K., & Cramer, D. W. (1999) · Human Reproduction · doi:10.1093/humrep/14.2.409 · Cited by 179
Age-dependent decrease in embryo implantation rate after in vitro fertilization
van Kooij, R. J., Looman, C. W. N., Habbema, J. D. F., Dorland, M., & Velde, E. R. T. (1996) · Fertility and Sterility · doi:10.1016/s0015-0282(16)58634-8 · Cited by 153
Winslow, K. L., Toner, J. P., Brzyski, R. G., Oehninger, S., Acosta, A. A., & Muasher, S. J. (1991) · Fertility and Sterility · doi:10.1016/s0015-0282(16)54604-4 · Cited by 130
de Boer, E. J., den Tonkelaar, I., Velde, E. R. T., Burger, C. W., Klip, H., & van Leeuwen, F. E. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)02972-2 · Cited by 123
Age and basal follicle stimulating hormone as predictors of in vitro fertilisation outcome
Sharif, K., Elgendy, M., Lashen, H., & Afnan, M. (1998) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1998.tb09360.x · Cited by 123
Bancsi, L. F. J. M. M., Huijs, A. M., den Ouden, C. T., Broekmans, F. J., Looman, C. W. N., Blankenstein, M. A., & Velde, E. R. T. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00552-x · Cited by 103
Nikolaou, D. (2002) · Human Reproduction · doi:10.1093/humrep/17.4.1106 · Cited by 90
Tremblay, J., Robert, N. M., & Viger, R. S. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.9.0692 · Cited by 76
Voutilainen, R., & Miller, W. L. (1987) · Molecular Endocrinology · doi:10.1210/mend-1-9-604 · Cited by 61
Elting, M. W., Kwee, J., Schats, R., Rekers-Mombarg, L. T. M., & Schoemaker, J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.4.7396 · Cited by 42
Harrell, F., Jr. (1996) · doi:10.1002/(sici)1097-0258(19960229)15:4<361::aid-sim168>3.0.co;2-4
Cited by
Weenen, C. (2004) · Molecular Human Reproduction · doi:10.1093/molehr/gah015 · Cited by 1,285
A systematic review of tests predicting ovarian reserve and IVF outcome
Broekmans, F. J., Kwee, J., Hendriks, D. J., Mol, B. W., & Lambalk, C. B. (2006) · Human Reproduction Update · doi:10.1093/humupd/dml034 · Cited by 1,258
Ovarian aging: mechanisms and clinical consequences
Broekmans, F. J., Soules, M. R., & Fauser, B. C. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0006 · Cited by 1,248
Self-citationTGF-β superfamily members and ovarian follicle development
Knight, P. G., & Glister, C. (2006) · Reproduction · doi:10.1530/rep.1.01074 · Cited by 1,173
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)
La Marca, A., Sighinolfi, G., Radi, D., Argento, C., Baraldi, E., Artenisio, A. C., Stabile, G., & Volpe, A. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmp036 · Cited by 956
Metadata
- Authors
- van Rooij, I. A. J.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-12-01
- Volume
- 17
- Issue
- 12
- Pages
- 3065-3071
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2132421508
- Cited by
- 951
- References
- 33
- FWCI
- 20.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.